Warren Ribley Named President & CEO Of iBio, Inc. (IBIO) And The iBIO Institute

The Illinois Biotechnology Industry Organization—better known as iBIO®--and its affiliate, the iBIO® Institute--today announced that Warren Ribley has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February 2015.

Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois' Health Technology Innovation center (HTI).

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.